SEC Form 3 · accession 0001213900-26-100650
Inmune Bio, Inc. · INMB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Sapirstein
Director
Period of report
Sep 8, 2026
Accepted (ET)
Sep 16, 2026 · 8:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001711754
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
No Table II lines on this filing.